Exercise for the Treatment of Cancer-Related Sarcopenia

Starting soon · Not applicable

Conditions studied: Cancer, Sarcopenia

In brief

Our primary objective is to assess the effects of exercise on cancer-related sarcopenia and its hallmarks, including muscle strength, muscle mass, and physical performance. The secondary objectives are to examine exercise adherence and the effects of exercise on health-related quality of life (QoL), cancer-related fatigue, and sleep quality. Additionally, we will explore the effects of exercise on bone and fat mass as secondary outcomes.

Key facts

Study ID

NCT07498985

Run by

State University of Londrina

People needed

78

Starts

2026-04-01

Expected to finish

2028-12-01

Last updated by the study team

2026-03-27

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• > 18 years old women with a confirmed diagnosis of breast or gynecological cancer.
• Any level of sarcopenia (pre-sarcopenia, sarcopenia, or severe sarcopenia).
• Patients must have completed their primary treatment regimen (surgery, chemotherapy, and/or radiotherapy) for at least 2 weeks and up to 2 years before enrolment.
• have received the medical consent to be engaged in physical exercise programs.

You may not qualify if…

• The presence of one or more comorbidities that could potentially interfere with attendance or test results (e.g., other cancers or acute or chronic renal failure);
• Already in exercise programs comparable to the HERA program;
• Evidence of severe cardiovascular disease as a result of an electrocardiogram.

Where it is running

• State University of Londrina — Londrina, Paraná, Brazil

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.